Publicacions (424) Publicacions de Rocío Aller De La Fuente

2024

  1. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346

  2. FIB-4 score as a predictor of COVID-19-related severity in hospitalized patients

    Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 465-471

  3. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

  4. Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

    Hepatology

  5. One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population

    United European Gastroenterology Journal, Vol. 12, Núm. 7, pp. 919-929

  6. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  7. Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease

    Gut, Vol. 73, Núm. 5, pp. 825-834

  8. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

  9. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597

2023

  1. AEEH «Consensus about detection and referral of hidden prevalent liver diseases»

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 236-247

  2. Association of the leptin receptor rs1805134 polymorphism with obesity parameters, dietary intakes, and metabolic syndrome in Caucasian obese subjects

    Nutricion Hospitalaria, Vol. 40, Núm. 1, pp. 35-40

  3. Dietary intervention with 2 different fat profiles; role of the rs822393 variant in metabolic parameter changes

    Nutricion Hospitalaria, Vol. 40, Núm. 1, pp. 49-58

  4. Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

    Contemporary Clinical Trials, Vol. 134

  5. Predicting liver-related events in NAFLD: A predictive model

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 4, pp. 1240-1251

  6. RS2289487 variation in PERILIPIN gene is a predictor of weight loss and protection against impaired glucose metabolism after a meal-replacement diet in postmenopausal obese females

    European review for medical and pharmacological sciences, Vol. 27, Núm. 19, pp. 9355-9362

  7. Relación del polimorfismo del gen de la resistina (rs7139228) con los niveles de resistina y el riesgo de síndrome metabólico en sujetos obesos

    Nutricion hospitalaria, Vol. 40, Núm. 2, pp. 325-331

  8. Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD

    Liver International, Vol. 43, Núm. 9, pp. 1909-1919

  9. Role of resistin (rs7139228) gene polymorphism with metabolic response after a hypocaloric mediterranean diet

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 2, pp. 88-97

2022

  1. A Pilot Study of Gene Expression Analysis in Peripheral Blood Mononuclear Cells in Response to a Hypocaloric Mediterranean Diet

    Disease markers, Vol. 2022, pp. 3706753

  2. A Randomized Trial with Two Hypocaloric Diets with Different Lipid Profiles and Effects on Serum Omentin-1 Levels in Obese Subjects

    Disease markers, Vol. 2022, pp. 6777283